Vitamin K2 may shield Kids' bones from steroid side effects
NCT ID NCT07206537
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether vitamin K2 supplements can prevent bone loss in children with nephrotic syndrome who are on long-term steroid therapy. Steroids are effective but can weaken bones, increasing fracture risk. The trial will enroll 60 children under 16 and measure changes in bone strength and bone-related blood markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Vitamin K2
- What this could lead to
- If it works, this could point toward a simple, safe way to protect bone health in children who need long-term steroids.
- What could go wrong
- This is a small, early-stage study (60 children) with no placebo group, so results may not be conclusive. Vitamin K2 may not prevent bone loss as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRICS NEPHROLOGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain Shams University
RECRUITINGCairo, Egypt